ED Raids Illegal Cough Syrup Racket
Analysis based on 6 articles · First reported Dec 12, 2025 · Last updated Dec 12, 2025
The illegal cough syrup trade and associated money laundering scheme, estimated at ₹1,000 crore, could negatively impact the pharmaceutical industry's reputation and regulatory scrutiny in India. The ongoing investigations by the India — Enforcement Directorate and India — Uttar Pradesh Police highlight significant financial crime, potentially leading to stricter enforcement and compliance costs for legitimate businesses.
The India — Enforcement Directorate (ED) conducted extensive raids across 25 locations in India — Uttar Pradesh, Jharkhand, and Gujarat as part of a money laundering investigation into an illegal codeine-based cough syrup trade racket. The probe, based on over 30 FIRs filed by India — Uttar Pradesh Police, targets main accused Shubham Jaiswal, his associates Alok Singh, Amit Singh, cough syrup manufacturers, and Chartered Accountant Vishnu Aggarwal. The estimated proceeds of crime are around ₹1,000 crore. Shubham Jaiswal is believed to have fled to United Arab Emirates — Dubai, and India — Uttar Pradesh Police have initiated extradition proceedings, while his father Bhola Prasad has been arrested. A Special Investigation Team (SIT) has been formed, and 32 individuals have been taken into custody. The illegal trade involved manufacturing, diversion, and cross-border transport of cough syrups, including to Bangladesh.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard